Literature DB >> 224454

Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus.

R B Tenser, R L Miller, F Rapp.   

Abstract

The incidence of trigeminal ganglion infection after corneal inoculation of guinea pigs with thymidine kinase-negative mutants of herpes simplex virus was markedly reduced compared to infection after inoculation of thymidine kinase-positive virus. Thymidine kinase-negative herpes simplex virus replicated well in ocular tissues in which dividing or potentially dividing cells were present, but not in trigeminal ganglion infection of nondividing neurons. Thymidine kinase-positive virus, however, replicated well in ocular tissues as well as in trigeminal ganglion. These results suggest that thymidine kinase expression of herpes simplex virus may be important in infections of sensory ganglia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 224454     DOI: 10.1126/science.224454

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  54 in total

1.  Failure of thymidine kinase-negative herpes simplex virus to reactivate from latency following efficient establishment.

Authors:  Shih-Heng Chen; Angela Pearson; Donald M Coen; Shun-Hua Chen
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 2.  Resistance of herpesviruses to antiviral drugs.

Authors:  P A Chatis; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

3.  Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells.

Authors:  Dongli Pan; Donald M Coen
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

4.  Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.

Authors:  M N Ellis; P M Keller; J A Fyfe; J L Martin; J F Rooney; S E Straus; S N Lehrman; D W Barry
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

5.  Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.

Authors:  S Kit; M Sheppard; H Ichimura; S Nusinoff-Lehrman; M N Ellis; J A Fyfe; H Otsuka
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

6.  Role of the VP16-binding domain of vhs in viral growth, host shutoff activity, and pathogenesis.

Authors:  Stephanie S Strand; David A Leib
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2.

Authors:  Y Nishiyama; H Kimura; T Daikoku
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

8.  Phosphorylation of herpes simplex virus 1 dUTPase regulates viral virulence and genome integrity by compensating for low cellular dUTPase activity in the central nervous system.

Authors:  Akihisa Kato; Jun Arii; Yoshio Koyanagi; Yasushi Kawaguchi
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

9.  Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus.

Authors:  T P Leist; R M Sandri-Goldin; J G Stevens
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus.

Authors:  L M Nutter; S P Grill; G E Dutschman; R A Sharma; M Bobek; Y C Cheng
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.